Sort   by:  
 Page size 
UnknownOptimizing the management of analytical interferences affecting red blood cells on XN-10 (Sysmex®).
Not available
S-EPMC9804823 | biostudies-literature
UnknownDifferential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
Not available
S-EPMC4506853 | biostudies-literature
UnknownAmerican Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version.
Not available
S-EPMC8135051 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
UnknownAdaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Not available
S-EPMC7612125 | biostudies-literature
UnknownLong-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
Not available
S-EPMC9095796 | biostudies-literature
UnknownEffect of mesenchymal stem cells on the host response in severe community-acquired pneumonia.
Not available
S-EPMC11503173 | biostudies-literature
UnknownCharacteristics of pharmacist's interventions triggered by prescribing errors related to computerised physician order entry in French hospitals: a cross-sectional observational study.
Not available
S-EPMC8506887 | biostudies-literature
UnknownSeverity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
Not available
S-EPMC7712850 | biostudies-literature
UnknownCOVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
Not available
S-EPMC7993930 | biostudies-literature
Sort   by:  
 Page size